Scott H. Dickerson

A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)

Edgar R. Wood, Anne T. Truesdale, Octerloney B. McDonald et al. · Cancer Research · 2004 · 1.1K citations · Full text

Crystal Structure, Molecular Biology, Cell Growth +20

Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by <i>NRAS</i> or <i>MEK</i> Mutations

James Greger, Stephen D. Eastman, Vivian Zhang et al. · Molecular Cancer Therapeutics · 2012 · 353 citations

Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2):  Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis

H. Neal Bramson, J. Corona, Stephen T. Davis et al. · Journal of Medicinal Chemistry · 2001 · 267 citations · Full text

Oxindole-based Inhibitors, Oxindole-based Compounds, Ligand Docking +16

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors

Tara Rheault, John Stellwagen, George M. Adjabeng et al. · ACS Medicinal Chemistry Letters · 2013 · 253 citations · Full text

B-raf-driven Tumors, Antitumor Activity, Hyperactive Signaling +16

Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors

Stephen T. Davis, Bill Benson, H. Neal Bramson et al. · Science · 2001 · 167 citations

Cdk Inhibitors, Chemoprevention Strategy, Hair Loss +11